- Novo Nordisk (NOV TH) +3.8%
- Novo Ozempic Kidney Trial Stopped Early; DaVita, Baxter Fall
- Gerresheimer (GXI TH) +3%
- Gerresheimer Rated New Overweight at Barclays; PT 120 euros
- Nel (D7G TH) +1.9%
- Delivery Hero (DHER TH) +1.1%
- Carlsberg (CBGB TH) +1%
- Carlsberg Rating Raised, Heineken Downgraded at Morgan Stanley
- Haleon (H6D0 TH) -1.3%
- Heineken (HNK1 TH) -1.3%
- Carlsberg Rating Raised, Heineken Downgraded at Morgan Stanley
- Hugo Boss (BOSS TH) -1.5%
- Ferrari (2FE TH) -1.8%
- LEG Immobilien (LEG TH) -1.9%
- LEG Immobilien Cut to Sell at Goldman; PT 51.40 euros
- HelloFresh (HFG TH) -2.6%
- Kering (PPX TH) -3.1%
- LVMH (MOH TH) -4.4%
- LVMH Falls on 3Q Miss, Luxury Sector Under Pressure: Street Wrap
- Fresenius SE (FRE TH) -5.6%
- Fresenius Medical (FME TH) -11%
- Novo Ozempic Kidney Trial Stopped Early; DaVita, Baxter Fall